3004046
print

JAK2 (V617F) Mutation by ddPCR, Qualitative

JAK2 QUAL
Example Reports
Detected
Not Detected

Icon

Informed Consent for Genetic Testing (required for NY patients)

Icon

Additional Technical Information

Ordering Recommendation

Aids in the workup of suspected myeloproliferative neoplasms. Use to detect the JAK2 V617F mutation in peripheral blood or bone marrow.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Whole blood or bone marrow in lavender (EDTA). Also acceptable: Whole blood in green (sodium heparin).

Specimen Preparation

Whole Blood: Do not freeze. Transport 5 mL whole blood. (Min: 1 mL)
Bone Marrow: Do not freeze. Transport 3 mL bone marrow. (Min: 1 mL)

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Plasma, serum, FFPE tissue blocks/slides, or fresh or frozen tissue. Specimens collected in anticoagulants other than EDTA. Clotted or grossly hemolyzed specimens.

Remarks
Stability

Refrigerated: 7 days; Frozen: Unacceptable

Methodology

Droplet Digital PCR (ddPCR)

Performed

Varies

Reported

2-9 days

Reference Interval

Interpretive Data

Refer to report. 

Compliance Category

Laboratory Developed Test (LDT)

Note

Hotline History

N/A

CPT Codes

81270

Are you an ARUP Client? Click here for your pricing.

Components

Component Test Code* Component Chart Name LOINC
3004047 JAK2 QUAL, Source 31208-2
3004048 JAK2 QUAL Mutation by PCR 43399-5
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • BCR-ABL1 negative testing
  • Classic BCR-ABL1-negative testing, mutant JAK2 V617F allelic burden
  • MPN JAK2
JAK2 (V617F) Mutation by ddPCR, Qualitative